Smith Graham & Co Investment Advisors’s Opko Health OPK Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-607,102	Closed	-$2.98M	–	133
2017 Q4	$2.98M	Buy	607,102 +11,720	+2%	+$68K	0.28%	130
2017 Q3	$4.08M	Sell	595,382 -6,130	-1%	-$38.6K	0.43%	117
2017 Q2	$3.96M	Sell	601,512 -32,810	-5%	-$230K	0.43%	117
2017 Q1	$5.08M	Sell	634,322 -12,010	-2%	-$101K	0.54%	84
2016 Q4	$6.01M	Buy	646,332 +61,230	+10%	+$633K	0.65%	68
2016 Q3	$6.2M	Buy	585,102 +16,930	+3%	+$169K	0.79%	51
2016 Q2	$5.31M	Sell	568,172 -36,880	-6%	-$374K	0.73%	59
2016 Q1	$6.29M	Buy	605,052 +21,240	+4%	+$194K	0.82%	45
2015 Q4	$5.87M	Sell	583,812 -17,120	-3%	-$172K	0.83%	48
2015 Q3	$5.05M	Buy	+600,932	New	+$7.95M	0.74%	60

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MSL

Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Smith Graham & Co Investment Advisors's OPK Position: Q1 2018 in Review

Smith Graham & Co Investment Advisors sold out of Opko Health (OPK) in Q1 2018, closing a stake of 607,102 shares — an estimated $2.98M sold.

Smith Graham & Co Investment Advisors first reported a position in OPK in Q3 2015 and held it in 10 quarters. The position peaked at $6.29M in Q1 2016. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2018.

Smith Graham & Co Investment Advisors reported no remaining Opko Health position as of Q1 2018 after selling out during the quarter.
Smith Graham & Co Investment Advisors sold 607,102 Opko Health shares in Q1 2018, an estimated $2.98M.
Smith Graham & Co Investment Advisors first reported a position in Opko Health in Q3 2015 and held it in 10 quarters.
Smith Graham & Co Investment Advisors's Opko Health position peaked at $6.29M in Q1 2016.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2018.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.